Alvotech Initiates Clinical Studies for AVT04, a Proposed Biosimilar to Stelara® (Ustekinumab),

“We are pleased to have reached this important milestone where the first subjects are being enrolled in clinical trials for AVT04, and we look forward to …, “We are pleased to have reached this important milestone where the first subjects are being enrolled in clinical trials for AVT04, and we look forward to …, Read More

Scroll to Top